Summary
Introduction
Based on the finding that pharmacological elevation of circulating angiotensin I1 (AII) levels reduces renin release, it has been proposed that renin secretion is controlled by a negative feedback system (Vander, 1967) . If this system is of physiological importance, lowering the circulating level of endogenous angiotensin should produce a reciprocal increase in renin secretion. Evidence for such a response has been obtained in rats (Bing, 1973) and renal hypertensive dogs (Miller, Samuels, Haber & Barger, 1972) treated with angiotensin-converting enzyme inhibitor. The aim of the present experiments was to determine whether interruption of the negative feedback loop by active immunization against A11 or by intravenous or intrarenal infusion of the competitive inhibitor, Sar'-Alas-angiotensin 11, would also lead to increased renin release.
Materials and methods
Experiments were performed in New Zealand white rabbits (2.5-4.0 kg) and adult Wistar rats (480-530 g) allowed free access to a standard pellet diet and tap water.
Group I. Six rabbits were immunized against A11 as described by Oates & Stokes (1974) . Five rabbits were mock-immunized. Each week I ml of blood was taken for measuring plasma renin activity and antibodies against AII.
Group II. In eleven male rabbits, 3 weeks after right nephrectomy and 2 days after catheterization of the left renal blood vessels, catheters were inserted into the central ear vessels and bladder, under local anaesthesia. Arterial blood pressure and renal plasma flow (p-aminohippurate clearanceirenal extraction ratio) were then measured with the animal sitting in a box (Stokes & Korner, 1964) . Arterial and renal vein blood samples, totalling 15 ml in 3 h, were replaced serially by a protein-saline solution (Weber, Thornell & Stokes, 1973) . Arterial pressure, renal blood flow and plasma renin activity were measured before, during and after a 1 h infusion of Sar '-Alas-angiotensin I1 (P-113, Norwich Pharmacal Co.), 0.055-1.1 nmol min-I k g -' in 154 mmol/l sodium chloride solution (saline; 0.02 mlimin) into the renal artery. Groups IIla and 1116. Twenty rats, anaesthetized withhactin (100 mg/kg intraperitoneally ; Promonta, Hamburg), were tracheotomized, vagotomized and given atropine sulphate (1.5 mg/kg, intramuscularly) and pentolinium tartrate (25 mg/kg, intramuscularly). Catheters were inserted into the right jugular vein and common carotid artery. Arterial blood samples (0.5 ml) were withdrawn each 30 min. After the third sample, group IIIa were infused intravenously for 1 h with inhibitor P-113, 5.5 nmol min-' kg-I, in 0.17 ml of physiological saline, whereas group IIIb received a control intravenous infusion of 0.17 ml of saline for 1 h. Blood samples were then taken for a further 2 h. The dose of inhibitor P-113 used herein greatly reduces the pressor response of rats to A11 but not that to noradrenaline (Oates, Stokes & Glover, 1974).
Plasma renin activity, plasma renin concentration and angiotensin antibody titres were measured by radioimmunoassay (Oates & Stokes, 1974) .
Results

Group Z
Mean PRA") during a 6 weeks pre-immunization period was 17.4t1.3 (SEM) ng h-I m1-I. During the first week that antibody against A11 was detected (mean titre 1/10 000), PRA increased ( P < 0.02) to 263%, reaching 45.7 t 10.7. It then fell despite progressive increases in anti-A11 antibody titres.
Mean PRA after mock-immunization was not significantly different from the control rabbit values.
Group I I
The effects of 1 h infusions of inhibitor P-113 into ( I ) Abbreviations: PRA, plasma renin activity; AII, angiotensin 11; a-v, arteriovenous.
Feedback control of renin release 35s
the renal arteries of one-kidney conscious rabbits are shown in Fig. 1 . During the control period, the renal arteriovenous (a-v) PRA difference indicated net renin secretion in each animal. Mean control arterial PRA was 17.9L4.0 (SEM) ng h-' m1-I (n = 11) and mean control renal vein PRA was 24.9. During and after infusion of inhibitor P-113 at 0.055 nmol min-I kg-I in two animals there were no changes in mean arterial pressure or renal blood flow. Arterial PRA and renal a-v PRA difference rose slightly during the infusion. Within 50 min of starting infusion of inhibitor P-113 at 0.22 nmol min-l kg-1 (n = 6), mean arterial pressure fell by 9.7 mmHg (P<O.O5) and mean arterial PRA rose to 267% of the control value (P<O.O5). Renal a-v PRA difference reached a mean value of 348% of control (P<O.Ol) at 30 min and then fell. Mean renal blood flow did not change (n = 4). Infusion of inhibitor P-113, 1.1 nmol min-kg-', produced falls in arterial pressure (mean 14 mmHg) and renal blood flow in all three animals tested. Changes in arterial PRA and renal a-v PRA difference paralleled those obtained with infusion of 0.22 nmol min-I kg-I inhibitor, but were greater in magnitude. During the 1 h period after infusion of the medium and high doses of inhibitor P-113, the measured variables reverted to their pre-infusion values in most animals.
Groups IIIa and IIIb
Mean values for PRA and plasma renin concentration in the three serial pre-infusion samples were constant within both groups of rats (range: PRA 2.0-2.3; plasma renin concentration 70.1-78.1 ng h-I ml-I). They remained constant for 1.5 h after the infusion of saline for 1 h (group Illb). However, infusion of inhibitor P-113 for 1 h (group IIIa) resulted in a steep rise in PRA to 652% of control value (P<0901) and in plasma renin concentration to 724% ( P < 0.00l). Thirty minutes after stopping the infusion, PRA had fallen to 300% and plasma renin concentration to 278% of preinfusion values, but even after 1.5 h a small but insignificant difference in mean values remained between group IIIa and group IIIb.
Immediately after starting infusion of inhibitor P-113, blood pressure rose transiently by 8 mmHg. A similar rise occurred on stopping the infusion. At no stage, however, were the mean values for pressure or heart rate of group IIIa rats significantly different from those of group IIIb.
Discussion
Previous studies in sodium-depleted or cavalconstricted dogs (Johnson & Davis, 1973) and in adrenalectomized rats (Bing, 1973) have shown that PRA increases during infusion of inhibitor P-113. However, these studies, in which arterial pressure, where reported, was reduced, have not established whether the rise in PRA was produced by interruption of AII-mediated feedback control of renin release or by baroreceptor stimulation. The present experiments have established that inhibitor P-113, 5.5 nmol min-l kg-', increases PRA and plasma renin concentration in ganglion-blocked, vagotomized rats without significant effects upon their arterial pressure or heart rate.
In conscious rabbits, infusion of inhibitor P-113, 0.22 nmol min -kg-I , into the renal artery caused rises in arterial PRA and renal a-v PRA difference without change in renal blood flow, constituting direct evidence of increased renin secretion. I t seems unlikely that this was secondary to hypotension, for the peak response in renin secretion preceded the lowest arterial pressure. Also, a fourfold rise in renin secretion was observed in one rabbit despite a definite increase in its arterial pressure during infusion of inhibitor P-113. The asynchrony between the peak renin response and the cessation of infusion of inhibitor P-I13 is consistent with initial interruption of the All feedback loop, followed by breakthrough of the blockade by rising arterial A11 concentrations.
The rise in PRA in AII-immunized rabbits suggests that renin release also increases when the concentration of free circulating A11 is reduced, again consistent with the properties of a negative feedback system, The secondary fall in PRA observed in this group has been discussed (Oates 8c Stokes, 1974). 1161-1 164.
